Solid Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	159.39	59.9	80.24	74.02	155.38	119.14
Short-Term Investments	218.28	127.95	68.69	49.63	58.34	88.64
Cash & Short-Term Investments	377.68	187.85	148.92	123.64	213.72	207.78
Cash Growth	40.87%	26.14%	20.45%	-42.15%	2.86%	34.27%
Receivables	-	-	-	-	-	0.11
Prepaid Expenses	2.93	2.42	1.65	2.11	3	8.71
Restricted Cash	0.64	1.22	-	-	-	-
Other Current Assets	13.86	13.97	6.73	3.98	2.91	6.02
Total Current Assets	395.11	205.46	157.3	129.73	219.64	222.61
Property, Plant & Equipment	24.63	26.09	29.04	33.16	38.61	7.6
Other Long-Term Assets	0.85	0.99	2.32	2.04	2.01	2.16
Total Assets	420.58	232.54	188.66	164.94	260.25	232.38
Accounts Payable	4.36	3.22	4.24	2.03	3.24	4.46
Accrued Expenses	17.79	18.95	19.85	10.16	16.69	9.53
Current Portion of Leases	2.23	2.1	3.02	2.32	2.57	1.5
Current Unearned Revenue	-	-	-	-	-	8.08
Other Current Liabilities	4.2	9.2	3.15	-	0.01	0.04
Total Current Liabilities	28.58	33.47	30.26	14.52	22.51	23.6
Long-Term Leases	17.92	19.06	21.16	23.94	25.98	0.57
Other Long-Term Liabilities	-	-	-	-	0.1	-
Total Liabilities	46.51	52.53	51.42	38.46	48.59	24.17
Common Stock	0.11	0.08	0.04	0.02	0.02	0.01
Additional Paid-In Capital	1,443	1,138	920.61	785.2	774.45	685.01
Retained Earnings	-1,069	-957.78	-783.45	-658.75	-562.74	-476.76
Comprehensive Income & Other	-0.11	0.05	0.05	0.02	-0.07	-0.05
Total Common Equity	374.08	180.01	137.25	126.48	211.67	208.21
Shareholders' Equity	374.08	180.01	137.25	126.48	211.67	208.21
Total Liabilities & Equity	420.58	232.54	188.66	164.94	260.25	232.38
Total Debt	20.16	21.16	24.18	26.27	28.55	2.06
Net Cash (Debt)	357.52	166.69	124.74	97.38	185.18	205.72
Net Cash Growth	45.89%	33.63%	28.11%	-47.41%	-9.98%	37.52%
Net Cash Per Share	3.23	1.90	3.06	4.90	21.75	28.90
Filing Date Shares Outstanding	107.23	98.39	77.49	37.76	19.57	7.36
Total Common Shares Outstanding	105.13	78.97	40.47	20.39	19.56	7.36
Working Capital	366.52	171.98	127.05	115.22	197.13	199.01
Book Value Per Share	3.56	2.28	3.39	6.20	10.82	28.30
Tangible Book Value	374.08	180.01	137.25	126.48	211.67	208.21
Tangible Book Value Per Share	3.56	2.28	3.39	6.20	10.82	28.30
Machinery	-	17.41	16.1	17.92	17.96	11.37
Construction In Progress	-	0.4	0.88	0.41	1.72	1.49
Leasehold Improvements	-	0.48	0.47	0.48	0.38	4.71

SEC Filings: 10-K · 10-Q